`Filed: July 24, 2015
`
`Naveen Modi
`Paul Hastings LLP
`875 15th Street NW
`Washington, DC 20005
`Telephone: (202) 551-1990
`Facsimile: (202) 551-0490
`E-mail: naveenmodi@paulhastings.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`THE MANGROVE PARTNERS MASTER FUND, LTD.
`Petitioner
`
`v.
`
`VIRNETX INC.
`Patent Owner
`
`
`
`
`
`
`
`Case IPR2015-01046
`Patent 6,502,135
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner’s Preliminary Response
`to Petition for Inter Partes Review
`of U.S. Patent No. 6,502,135
`
`
`
`
`Filed on behalf of: VirnetX Inc.
`By:
`
`Joseph E. Palys
`Paul Hastings LLP
`875 15th Street NW
`Washington, DC 20005
`Telephone: (202) 551-1996
`Facsimile: (202) 551-0496
`E-mail: josephpalys@paulhastings.com
`
`
`
`
`
`
`
`I.
`
`II.
`
`
`
`Case No. IPR2015-01046
`
`Table of Contents
`
`Introduction ...................................................................................................... 1
`
`The Petition Fails to Meet the Requirements for Instituting an
`Inter Partes Review ......................................................................................... 2
`
`A.
`
`The Petition Fails to Name All of the Real Parties-in-Interest ............. 2
`
`1.
`
`2.
`
`3.
`
`4.
`
`The Mangrove Partners Hedge Fund and Nathaniel
`August ......................................................................................... 3
`
`The US Feeder, the Cayman Feeder, and Mangrove
`Capital ......................................................................................... 8
`
`The Unnamed Investors ............................................................ 10
`
`The Petition Should Be Denied For Failing to Identify
`All RPIs ..................................................................................... 11
`
`B.
`
`C.
`
`D.
`
`E.
`
`The Petition Was Filed for an Improper Purpose ............................... 13
`
`The Petition Fails to Show a Reasonable Likelihood That
`Petitioner Will Prevail With Respect to Any Claim ........................... 15
`
`The Petition Should Be Denied Under 35 U.S.C. § 325(d) ................ 17
`
`The Petition Improperly Relies on Material That It Fails to
`Establish Is Statutory Prior Art ........................................................... 20
`
`III. The Petition’s Claim Constructions Are Flawed and Should Be
`Rejected ......................................................................................................... 27
`
`A. Overview of the ’135 Patent ................................................................ 28
`
`B.
`
`C.
`
`D.
`
`E.
`
`Level of Ordinary Skill in the Art ....................................................... 29
`
`“Virtual Private Network (VPN)” (Claims 1, 4, 10, and 12) .............. 31
`
`“Domain Name” (Claim 10) ............................................................... 38
`
`“Domain Name Service (DNS) Request” (Claims 1, 3, 4, 8, 10,
`12) ........................................................................................................ 39
`
`i
`
`
`
`
`
`F.
`
`G.
`
`H.
`
`Case No. IPR2015-01046
`
`“DNS Proxy Server” (Claims 8, 10) ................................................... 41
`
`“Client Computer” (Claims 1, 3, 4, 7, 10, 12) .................................... 41
`
`“Automatically Initiating the VPN” (Claims 1, 4, 5) .......................... 44
`
`IV. Conclusion ..................................................................................................... 47
`
`
`
`
`
`
`
`ii
`
`
`
`
`
`Case No. IPR2015-01046
`
`TABLE OF AUTHORITIES
`
` Page(s)
`
`Cases
`A.R.M., Inc. v. Cottingham Agencies Ltd.,
`IPR2014-00671, Paper No. 10 (Oct. 3, 2014) .................................................... 20
`
`Actavis, Inc. v. Research Corp. Techs., Inc.,
`IPR2014-01126, Paper No. 22 (Jan. 9, 2015) ..................................................... 20
`
`Apple Inc. v. Contentguard Holdings, Inc.,
`IPR2015-00450, Paper No. 9 (June 29, 2015) .................................................... 22
`
`Cisco Sys., Inc. v. C-Cation Techs., LLC,
`IPR2014-00454, Paper No. 12 (Aug. 29, 2014) ................................................. 23
`
`Elec. Frontier Found. v. Pers. Audio, LLC,
`IPR2014-00070, Paper No. 21 (Apr. 18, 2014) .................................................. 26
`
`Galderma S.A. v. Allergan Industrie, SAS,
`IPR2014-01422, Paper No. 14 (Mar. 5, 2015) ................................................. 4, 7
`
`Garmin Int’l, Inc. v. Cuozzo Speed Techs. LLC,
`IPR2012-00001, Paper No. 15 (Jan. 9, 2013) ............................................... 28, 37
`
`GEA Process Eng., Inc. v. Steuben Foods, Inc.,
`IPR2014-00041, Paper No. 15 (Dec. 23, 2014) .................................................. 12
`
`Heckler v. Chaney, 470 U.S. 821, 831 (1985) ......................................................... 14
`
`In re Klopfenstein, 380 F.3d 1345 (Fed. Cir. 2004) ................................................ 20
`
`In re Zletz, 893 F.2d 319 (Fed. Cir. 1989) ............................................................... 27
`
`Integrated Global Concepts, Inc. v. Advanced Messaging Techs., Inc.,
`IPR2014-01028, Paper No. 13 (Dec. 22, 2014) .................................................. 19
`
`Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd.,
`IPR2013-00324, Paper No. 19 (Nov. 21, 2013) ................................................. 19
`
`L-3 Comm. Holdings, Inc. v. Power Survey, LLC,
`IPR2014-00832, Paper No. 9 (Nov. 14, 2014) ................................................... 20
`
`
`
`iii
`
`
`
`
`Microsoft Corp. v. Proxyconn, Inc.,
`No. 2014-1542, -1543, 2015 U.S. App. LEXIS 10081 (Fed. Cir.
`Jun. 16, 2015) .......................................................................................... 28, 37, 38
`
`Case No. IPR2015-01046
`
`Motorola Solutions, Inc. v. Mobile Scanning Techs., LLC,
`IPR2013-00093, Paper No. 28 (Apr. 29, 2013) ............................................ 28, 37
`
`Phillips v. AWH Corp.,
`415 F.3d 1303 (Fed. Cir. 2005) (en banc) .......................................................... 27
`
`RPX Corp. v. VirnetX, Inc.,
`IPR2014-00171, Paper No. 52 (June 23, 2014) .................................................. 11
`
`Samsung Elecs. Co. v. Rembrandt Wireless Techs., LP,
`IPR2014-00514, Paper No. 18 (Sep. 9, 2014) .............................................. 25, 26
`
`Square, Inc. v. Unwired Planet, LLC,
`CBM2014-00156, Paper 22 (Feb. 26, 2015) ................................................ 21, 22
`
`Taylor v. Sturgell, 553 U.S. 880, 894 (2008) ........................................................... 11
`
`VirnetX, Inc. v. Cisco Sys., Inc.,
`767 F.3d 1308 (Fed. Cir. 2014) .................................................... 5, 15, 16, 17, 44
`
`Zerto Inc. v. EMC Corp.,
`IPR2014-01329, Paper No. 33 (Mar. 3, 2015) ................................................... 10
`
`Zetec, Inc. v. Westinghouse Elec. Co.,
`IPR2014-00384, Paper No. 10 (July 23, 2014) .................................................. 14
`
`Zoll Lifecor Corp. v. Philips Elecs. N. Am. Corp.,
`IPR2013-00606, Paper No. 13 (Mar. 20, 2015) ................................................. 13
`
`Federal Statutes
`
`35 U.S.C. § 311(b) ....................................................................................... 20, 24, 25
`
`35 U.S.C. § 312(a)(2) ....................................................................................... 1, 2, 11
`
`35 U.S.C. § 313 .......................................................................................................... 1
`
`35 U.S.C. § 314(a) ............................................................................................. 14, 15
`
`35 U.S.C. § 316 ........................................................................................................ 14
`
`
`
`iv
`
`
`
`
`35 U.S.C. § 325(d) ............................................................................. 1, 17, 18, 19, 20
`
`Case No. IPR2015-01046
`
`Federal Rules
`
`37 C.F.R. § 42.6(a)(3) ........................................................................................ 22, 32
`
`37 C.F.R. § 42.11 ..................................................................................................... 13
`
`37 C.F.R. § 42.65(a) ................................................................................................. 24
`
`37 C.F.R. § 42.107 ..................................................................................................... 1
`
`37 C.F.R. § 42.100(b) .............................................................................................. 27
`
`Other Authorities
`
`77 Fed. Reg. 157 (Aug. 14, 2012) .............................................................. 3, 7, 10, 18
`
`157 Cong. Rec. S1041-42 (daily ed. Mar. 1, 2011) ................................................. 18
`
`
`
`v
`
`
`
`
`
`
`
`
`
`I.
`
`
`
`Case No. IPR2015-01046
`
`Introduction
`The Petition for Inter Partes Review (the “Petition”) filed by The Mangrove
`
`Partners Master Fund, Ltd. against Patent Owner’s U.S. Patent No. 6,502,135 (“the
`
`’135 patent”) is part of a rapidly expanding group of controversial filings by hedge
`
`funds using the inter partes review process to move stock prices and reap profits.
`
`Patent Owner VirnetX Inc. respectfully submits this Preliminary Response in
`
`accordance with 35 U.S.C. § 313 and 37 C.F.R. § 42.107. Patent Owner requests
`
`that the Board not institute inter partes review for several reasons.
`
`First, the Petition fails to name all of the real parties-in-interest (“RPIs”) as
`
`required by 35 U.S.C. § 312(a)(2). As explained below, various entities associated
`
`with a hedge fund named Mangrove Partners should have been named as RPIs.
`
`Second, the Petition was filed in an attempt to manipulate the publicly traded stock
`
`of Patent Owner’s parent company, VirnetX Holding Corporation, which is an
`
`improper purpose that the Board should not condone. Third, the Petition has not
`
`met its burden of demonstrating a reasonable likelihood of prevailing in proving
`
`unpatentability of any challenged claim of the ’135 patent. Fourth, because the
`
`same or substantially the same prior art has been before the Office, and because the
`
`Petition represents the tenth attempt to challenge the validity of the ’135 patent at
`
`the Office, the Petition should be denied under 35 U.S.C. § 325(d). And finally,
`
`the Petition proposes a number of incorrect claim constructions upon which it
`
` 1
`
`
`
`
`
`
`bases its unpatentability grounds. Each of these reasons requires denial of
`
`Case No. IPR2015-01046
`
`institution.
`
`II. The Petition Fails to Meet the Requirements for Instituting an
`Inter Partes Review
`A. The Petition Fails to Name All of the Real Parties-in-Interest
`A petition may only be considered if it “identifies all real parties in interest.”
`
`35 U.S.C. § 312(a)(2). The Petition names The Mangrove Partners Master Fund,
`
`Ltd. (“Petitioner,” a.k.a. “Cayman Master”) as the only RPI. This allegation is
`
`inconsistent with filings made by the Petitioner and parties that control the
`
`Petitioner at the Securities and Exchange Commission (“SEC”). In particular, as
`
`described in more detail below, the Petitioner is part of a complex web of entities
`
`that are linked to a hedge fund registered in the Cayman Islands called Mangrove
`
`Partners (hereinafter referred to as “the Mangrove Partners Hedge Fund”), a
`
`different entity than similarly named Petitioner. (Ex. 2001, Mangrove Partners
`
`Brochure at 3-4; Ex. 2002, Schedule A at 1-2; Ex. 2003, Cayman Islands Search
`
`Report at 1.) The Petition fails to name a number of RPIs, including at least (1) the
`
`Mangrove Partners Hedge Fund; (2) Nathaniel August (President and majority
`
`owner of the Mangrove Partners Hedge Fund); (3) The Mangrove Partners Fund,
`
`L.P. (“the US Feeder”); (4) The Mangrove Partners Fund (Cayman), Ltd. (“the
`
`Cayman Feeder”); (5) Mangrove Capital (the General Partner of the US Feeder);
`
`and (6) the unnamed investors in the US Feeder and the Cayman Feeder. Below is
`
`
`
`2
`
`
`
`
`a chart exemplifying the relationship between these entities (collectively referred
`
`Case No. IPR2015-01046
`
`to as “the Mangrove entities”).
`
`
`
`The Mangrove Partners Hedge Fund and Nathaniel August
`
`1.
`The control and funding of an IPR are important factors that the Board must
`
`consider in determining whether a party is an RPI. Office Patent Trial Practice
`
`Guide, 77 Fed. Reg. 157 at 48759-60 (Aug. 14, 2012). “Evidence that a non-party
`
`wields ‘substantial control’ in a matter ‘may be overt or covert, and the evidence of
`
`
`
`3
`
`
`
`
`it may be direct or circumstantial—so long as the evidence as a whole shows that
`
`Case No. IPR2015-01046
`
`the nonparty possessed effective control over a party’s conduct . . . as measured
`
`from a practical, as opposed to a purely theoretical, standpoint.” Galderma S.A. v.
`
`Allergan Industrie, SAS, IPR2014-01422, Paper No. 14 at 7 (Mar. 5, 2015) (citing
`
`Gonzalez v. Banco Cent. Corp., 27 F.3d 751, 759 (1st Cir. 1994)).
`
`The Mangrove Partners Hedge Fund is “the investment manager for The
`
`Mangrove Partners Fund, L.P., a Delaware limited partnership (the ‘US Feeder’),
`
`The Mangrove Partners Fund (Cayman), Ltd., a Cayman Islands exempted
`
`company (the ‘Cayman Feeder’), [and Petitioner,] The Mangrove Partners Master
`
`Fund, Ltd., a Cayman Islands exempted company (the ‘Cayman Master’) [i.e., the
`
`Petitioner].” (Ex. 2001 at 3.) All of the funds have a “shared investment objective
`
`. . . [to] compound their net worth while minimizing the chances of a permanent
`
`loss of capital.” (Ex. 2001 at 4.) In order to achieve this “shared investment
`
`objective,” the Mangrove Partners Hedge Fund has “complete discretion regarding
`
`the investment of [the US Feeder’s, the Cayman Feeder’s, and Petitioner’s] assets
`
`in accordance with the investment objectives, policies and parameters set forth in
`
`the applicable offering documents of each Fund.” (Ex. 2001 at 3, 17 (emphasis
`
`added).) The Mangrove Partners Hedge Fund views itself as having a “fiduciary
`
`duty” to invest in a manner that increases profits for its investors. (Ex. 2001 at 13.)
`
`
`
`4
`
`
`
`
`
`Case No. IPR2015-01046
`
`In exercising their investment objectives and fiduciary duties, the Mangrove
`
`entities pursued short positions in the publicly traded stock of Patent Owner’s
`
`parent company, VirnetX Holding Corporation (“VHC”). In particular, on
`
`February 17, 2015, prior to when Petitioner, The Mangrove Partners Master Fund,
`
`Ltd., filed the Petition, the Mangrove Partners Hedge Fund held a short position of
`
`270,000 shares of VHC stock via put options. (Ex. 2004, Form 13-F dated
`
`February 17, 2015 at 2.) A “put option buyer hopes the stock will drop in price,”
`
`increasing the value of the put option. (Ex. 2005 at 3.) On April 14, 2015, in an
`
`apparent attempt to encourage such a drop in VHC’s stock price, Petitioner filed
`
`the Petition in this proceeding as well as another petition in IPR2015-01047,
`
`targeting two patents the Federal Circuit confirmed as valid and infringed. See
`
`VirnetX, Inc. v. Cisco Sys., Inc., 767 F.3d 1308, 1313-14 (Fed. Cir. 2014). On May
`
`15, 2015, after any volatility created by the Petition would have subsided, the
`
`Mangrove Partners Hedge Fund no longer held the short position in VHC’s stock.
`
`(Ex. 2006, Form 13-F dated May 15, 2015 at 2.) This demonstrates that the
`
`Petition was part of a coordinated investment strategy by at least the Petitioner and
`
`the Mangrove Partners Hedge Fund to manipulate VHC’s stock price.
`
`The Mangrove Partners Hedge Fund’s complete discretionary control over
`
`Petitioner is not merely theoretical given that The Mangrove Partners Hedge Fund
`
`has repeatedly demonstrated that, in practice, it exercises total control over
`
`
`
`5
`
`
`
`
`Petitioner. For example, the Mangrove Partners Hedge Fund and Nathaniel August
`
`Case No. IPR2015-01046
`
`(President of the Mangrove Partners Hedge Fund and owner of somewhere
`
`between 50-75% of the Mangrove Partners Hedge Fund (see Ex. 2002at 1-2)) have
`
`signed, on behalf of Petitioner, every single public document associated with
`
`Petitioner that is available in the U.S. Securities and Exchange Commission’s
`
`EDGAR database. (See, e.g., Ex. 2007 at 12; Ex. 2008 at 12; Ex. 2009 at 11; Ex.
`
`2010 at 11; Ex. 2011 at 11; Ex. Ex. 2012 at 11; Ex. 2013 at 5.)1 As another
`
`example, when Petitioner issued a press release that it was nominating individuals
`
`to the Board of Directors of a company in which it was a significant shareholder,
`
`Petitioner (1) nominated Nathaniel August (the Mangrove Partners Hedge Fund’s
`
`President and majority owner), and (2) issued the press release on behalf of “The
`
`Mangrove Partners Master Fund, Ltd.[,] [the US Feeder,] [the Cayman Feeder,]
`
`[the] Mangrove Partners[ Hedge Fund,] Mangrove Capital[, and] Nathaniel
`
`August” (in addition to four other individuals), referring to itself “together with the
`
`other participants named herein [as] collectively, ‘Mangrove’.” (Ex. 2014 at 1, 3,
`
`4.) Thus, in addition to their current legal ability to control this proceeding, the
`
`1 In these documents, the Mangrove Partners Hedge Fund also signed on
`
`behalf of the other RPIs, including the US Feeder, the Cayman Feeder, and
`
`Mangrove Capital. (See, e.g., Ex. 2007 at 11-12; Ex. 2008 at 12; Ex. 2009 at 11;
`
`Ex. 2010 at 11; Ex. 2011 at 11; Ex. 2012 at 11; Ex. 2013 at 11.)
`
`
`
`6
`
`
`
`
`past behavior of the Mangrove Partners Hedge Fund and Nathaniel August
`
`Case No. IPR2015-01046
`
`demonstrates that they have the actual power to control this proceeding.
`
`The facts at hand are similar to those in Galderma. In particular, in
`
`Galderma, the Board found that where a President of a parent entity was also at the
`
`helm of the parent entity’s subsidiary, this “strongly implies ‘an involved and
`
`controlling parent corporation representing the unified interests of itself and
`
`Petitioner.” Galderma S.A., IPR2014-01422, Paper No. 14 at 12 (citing Zoll
`
`Lifecor Corp. v. Philips Elecs. N. Am. Corp., IPR2013-00606, Paper No. 13 at 10
`
`(Mar. 20, 2015)). The same is true for the relationship between Petitioner and the
`
`Mangrove Partners Hedge Fund, with Nathaniel August at the helm of both
`
`entities.
`
`The Board has acknowledged that it “need not consider whether [a party] did
`
`or did not, directly or indirectly, exercise [its] control.” Galderma S.A., IPR2014-
`
`01422, Paper No. 14 at 12. Rather, for purposes of finding that a party is an RPI, it
`
`is sufficient that the party had the power “to call the shots.” Id. (citing Gonzalez,
`
`27 F.3d at 758); see also 77 Fed. Reg. at 48759 (“The concept of control generally
`
`means that ‘it should be enough that the nonparty has the . . . opportunity to control
`
`. . . .’”) (emphasis added). As demonstrated by their past actual control and current
`
`ability to control, Mangrove Partners Hedge Fund and Nathaniel August have the
`
`power “to call the shots” in this proceeding. Therefore, both parties are RPIs and
`
`
`
`7
`
`
`
`
`both Mangrove Partners Hedge Fund and Nathaniel August should have been
`
`Case No. IPR2015-01046
`
`named as real parties-in-interest.
`
`The US Feeder, the Cayman Feeder, and Mangrove Capital
`
`2.
`The US Feeder and the Cayman Feeder “are constituents of a ‘master-
`
`feeder’ structure for which [Petitioner] serves as the master fund.” (Ex. 2001 at 3-
`
`4.) Mangrove Capital, a Cayman Islands exempted company, is an “affiliate” of
`
`the Mangrove Partners Hedge Fund and “serves as the general partner of the US
`
`Feeder.” (Id. at 3.) “Mangrove Capital is allocated 20% of the annual increase in
`
`the net worth of an Investor’s interest in a Fund.” (Id. at 4.) Moreover, “[a]ny
`
`persons acting on behalf of Mangrove Capital are subject to the supervision and
`
`control of [the Mangrove Partners Hedge Fund] in connection with any investment
`
`advisory activities.” (Id. at 13.)
`
`A master-feeder structure is commonly used by hedge funds to “permit[] the
`
`pooling of domestic and offshore capital in a single master fund, while affording
`
`flow-through tax treatment for U.S. taxable investors in the domestic feeder.” (Ex.
`
`2015 at 34.) “The hedge fund manager usually receives management fees and
`
`performance allocations from the domestic feeder fund in its role as that fund’s
`
`general partner or manager, and management and performance fees as an
`
`investment adviser pursuant to an investment contract with the offshore feeder
`
`fund.” (Id.) Consistent with the master-feeder structure, investments in the US
`
`
`
`8
`
`
`
`
`and Cayman Feeders are “allocated initially to the Cayman Master [i.e.,
`
`Case No. IPR2015-01046
`
`Petitioner],” and Petitioner is “owned by the US Feeder and the Cayman Feeder.”
`
`(Ex. 2001 at 15.) Because the US Feeder and the Cayman Feeder fund all of the
`
`activities of Petitioner (e.g., funding the investment in the filing of the Petition in
`
`this proceeding), receive management and investment fees from investors, and are
`
`co-owners of the Petitioner, the US Feeder and Cayman Feeder control Petitioner’s
`
`activities. (See id. at 15.) Indeed, all of the funds work together, having a “shared
`
`investment objective . . . [to] compound their net worth while minimizing the
`
`chances of a permanent loss of capital.” (Id. at 4.) Since the US Feeder and the
`
`Cayman Feeder both fund and have control over this proceeding, they are both
`
`RPIs.
`
`In addition, the Cayman Feeder shares a common mailing address and
`
`registration address with Petitioner in the Cayman Islands (see Ex. 2016 at 1, Ex.
`
`2017 at 1, Ex. 2018 at 1, Ex. 2019 at 1), and the US Feeder and Mangrove Capital
`
`share a common mailing address with the Mangrove Partners Hedge Fund in New
`
`York City (see Ex. 2020 at 1-2). Moreover, similar to the discussion above in Part
`
`II.A.1, the Mangrove Partners Hedge Fund, the US Feeder, the Cayman Feeder,
`
`Mangrove Capital, and Petitioner, have repeatedly acted as a single “entity,”
`
`blurring the lines between where one entity ends and another begins. (See, e.g.,
`
`Ex. 2014 at 1, 3, 4.) For instance, at least with respect to Mangrove Capital, the
`
`
`
`9
`
`
`
`
`President (Nathaniel August), Chief Operating Officer (Ward Dietrich), and Senior
`
`Case No. IPR2015-01046
`
`Analyst (Jeffrey Kalicka) are identical to those of the Mangrove Partners Hedge
`
`Fund. (See Ex. 2002 at 2.) In this very proceeding, Ward Dietrich held himself
`
`out as an “authorized person” to sign the Power of Attorney on behalf of Petitioner,
`
`further blurring the lines between Petitioner and the other RPIs. See Paper No. 2 at
`
`2. Therefore, the US Feeder, the Cayman Feeder, and Mangrove Capital would
`
`have had an actual measure of control over this proceeding. See Zerto Inc. v. EMC
`
`Corp., IPR2014-01329, Paper No. 33 at 10 (Mar. 3, 2015) (where entities are “so
`
`intertwined it is difficult for both insiders and outsiders to determine precisely
`
`where one ends and the other begins, there exists an actual measure of control or
`
`opportunity to control that reasonably might be expected between entities in such a
`
`relationship”).
`
`The Unnamed Investors
`
`3.
`As noted above, the funding of an IPR is an important factor that the Board
`
`must consider in determining whether a party is an RPI. Office Patent Trial
`
`Practice Guide, 77 Fed. Reg. 157 at 48760 (Aug. 14, 2012). Petitioner does not
`
`name the investors funding the Petition. However, the investors would have each
`
`provided substantial funding for the Petition since the Mangrove Partners Hedge
`
`Fund requires investors to provide a “minimum initial investment of $1,000,000.”
`
`(Ex. 2001 at 6.) The undisclosed investors that provided substantial funding for
`
`
`
`10
`
`
`
`
`the Petition are the parties that stand to gain or lose, and, therefore, are RPIs. See
`
`Case No. IPR2015-01046
`
`RPX Corp. v. VirnetX, Inc., IPR2014-00171, Paper No. 52 at 9 (June 23, 2014)
`
`(finding the petitioner to be “at most, a ‘nominal plaintiff’ with ‘no substantial
`
`interest’ in these IPR challenges apart from those of its client,” which was held to
`
`be an RPI).
`
`In addition, the Mangrove Partners Hedge Fund views itself as having a
`
`“fiduciary duty to [its] clients.” (Ex. 2001 at 13; see also id. at 5 (providing that
`
`the Mangrove Partners Hedge Fund will “from time to time enter into agreements
`
`with certain Fund investors that may provide for terms of investment that are more
`
`favorable than the terms described in the relevant Fund offering documents”).)
`
`The fiduciary relationship between the unnamed investors and the Mangrove
`
`Partners Hedge Fund further compels a finding that the investors are RPIs. See
`
`Taylor v. Sturgell, 553 U.S. 880, 894 (2008) (finding “fiduciaries” to be part of the
`
`third of six categories that create an exception to the common law rule that
`
`normally forbids nonparty preclusion in litigation); see also RPX Corp., IPR2014-
`
`00171, Paper No. 52 at 6 (relying on the six categories in Taylor to determine the
`
`scope of RPI).
`
`4.
`
`The Petition Should Be Denied For Failing to Identify All
`RPIs
`The requirement to identify all RPIs was created by statute. See 35 U.S.C.
`
`§ 312(a)(2). Failure to disclose all RPIs is a substantive defect. See, e.g., GEA
`
`
`
`11
`
`
`
`
`Process Eng., Inc. v. Steuben Foods, Inc., IPR2014-00041, Paper No. 15 at 10-13
`
`Case No. IPR2015-01046
`
`(Dec. 23, 2014). Although the Board has the discretion to authorize the correction
`
`of some deficiencies in a petition, the Board should not exercise its discretion to do
`
`so here. The Petitioner’s incorrect identification of the RPI is not a close question
`
`and should not be excused. Material information available to—and in fact
`
`produced by—Petitioner and its officers clearly establishes the Mangrove Partners
`
`Hedge Fund, Nathaniel August, the US Feeder, the Cayman Feeder, Mangrove
`
`Capital, and the unnamed investors in the US Feeder and the Cayman Feeder, as
`
`RPIs. See supra Part II. In light of this, Petitioner’s identification of itself as the
`
`only RPI is simply not objectively reasonable.
`
`The only conclusion that can be drawn from Petitioner’s attempt to hide
`
`these RPIs is that it was doing so in an attempt to shield them from any liability
`
`arising out of the filing of the Petition.2 But whether this is the case or not,
`
`Petitioner’s misidentification of the RPI violates its duty of candor to the Office.
`
`2 Consider, for example, the complaint filed against Ferrum Ferro Capital,
`
`LLC, an investment fund that filed the petition in IPR2015-00858, apparently
`
`employing a similar strategy to that of Petitioner and its RPIs. In the Complaint,
`
`Allergan (the patent owner) alleges that Ferrum Ferro Capital, LLC’s conduct
`
`“constitutes attempted civil extortion and malicious prosecution under California
`
`law in addition to violating California’s Unfair Competition Law.” See Ex. 2021.
`
`
`
`12
`
`
`
`
`See 37 C.F.R. § 42.11. Failure to identify all RPI frustrates the Office’s ability to
`
`Case No. IPR2015-01046
`
`determine any potential conflicts-of-interest and undermines the credibility of the
`
`evidence presented in the proceeding. Zoll Lifecor Corp. v. Philips Elecs. N. Am.
`
`Corp., IPR2013-00606, Paper No. 13 at 7-8 (Mar. 20, 2015). Petitioner’s
`
`unreasonable identification of RPI should not be endorsed. The Petition should be
`
`denied to discourage similar petitioners from likewise attempting to deceive the
`
`Office and to also encourage petitioners to make a reasonable and honest
`
`assessment of RPI before filing a petition.
`
`The Petition Was Filed for an Improper Purpose
`
`B.
`As discussed above, Petitioner is an entity controlled by the Mangrove
`
`Partners Hedge Fund. This proceeding was filed in an apparent attempt to
`
`manipulate the financial markets to increase the value of the Mangrove Partners
`
`Hedge Fund’s short position in VHC stock. (Ex. 2004 at 2; Ex. 2006 at 2.) In
`
`doing so, the Mangrove Partners Hedge Fund, and its related entities discussed
`
`above (including the Petitioner), followed the lead of the much-publicized and
`
`controversial IPR petitions of Hayman Capital and Kyle Bass.3 (See, e.g., Ex.
`
`
`3 To date, Hayman Capital/Kyle Bass have filed sixteen IPR petitions,
`
`including IPR2015-00720, -00817, -00988, -00990, -01018, -01076, -01086, -
`
`01092, -01093, -01096, -01102, -01103, -01136, -01169, -01241, and -01344.
`
`
`
`13
`
`
`
`
`2022 at 1 (“A well-known hedge-fund manager is taking a novel approach to
`
`Case No. IPR2015-01046
`
`making money: filing and publicizing patent challenges against pharmaceutical
`
`companies while also betting against their shares.”).) The Mangrove Partners
`
`Hedge Fund has even registered the Petitioner at an address that is identical to the
`
`address used to register the entities filing the petitions in the Hayman Capital/Kyle
`
`Bass petitions. (See, e.g., Ex. 2019 at 1; Ex. 2023 at 1.)4
`
`The standard for institution of an inter partes review under 35 U.S.C.
`
`§ 314(a) “is written in permissive terms. . . . Thus, Congress has given the office
`
`discretion whether to institute a review or not institute a review.” Zetec, Inc. v.
`
`Westinghouse Elec. Co., IPR2014-00384, Paper No. 10 at 5 (July 23, 2014); see
`
`also Heckler v. Chaney, 470 U.S. 821, 831 (1985). Congress also stated that, in
`
`prescribing regulations under 35 U.S.C. § 316, the Director shall consider the
`
`effect of any such regulation on things such as “the economy” and “the integrity of
`
`the patent system.” 35 U.S.C. § 316(b). The importance of these considerations is
`
`reflected in 35 U.S.C. § 316(a)(6), where Congress authorized the Director to
`
`
`Another investment fund, Ferrum Ferro Capital LLC, has also used a similar
`
`strategy with IPR2015-00858.
`
`4 This address appears to be that of a law firm based in the Cayman Islands.
`
`(Ex. 2024 at 1-2.)
`
`
`
`14
`
`
`
`
`prescribe sanctions for “abuse of discovery, abuse of process, or any other
`
`Case No. IPR2015-01046
`
`improper use of the proceeding.”
`
`Congress’ aim in establishing the IPR process was to “provid[e] quick and
`
`cost effective alternatives to litigation[,] . . . not . . . [a] tool[] for harassment.” See
`
`H.R. Rep. No. 112-98, pt. 1, at 48. There can be no dispute that allowing hedge
`
`funds to use the IPR process to manipulate financial markets is inconsistent with
`
`Congressional intent and the directives given to the Office. Instituting inter partes
`
`review here will only encourage more such filings, which will burden additional
`
`patent owners, their industries, and the Office. The Board should, therefore,
`
`exercise its discretion under § 314(a) and refuse to institute this IPR.
`
`C. The Petition Fails to Show a Reasonable Likelihood That
`Petitioner Will Prevail With Respect to Any Claim
`
`The impropriety of the Petition does not stop at its purpose. The Petition
`
`fails to even mention, let alone analyze, the fact that the Court of Appeals for the
`
`Federal Circuit has already opined on whether Kiuchi anticipates, inter alia, the
`
`claims of the ’135 patent. See VirnetX, Inc., 767 F.3d at 1323-24. This is despite
`
`the fact that the Federal Circuit decision came seven months before the Petition
`
`was filed.
`
`According to the Federal Circuit, there was “substantial evidence that at
`
`least one element of each asserted claim [of the ’135 patent] was missing from [the
`
`Kiuchi] reference,” including evidence that “Kiuchi’s proxy servers at least do not
`
`
`
`15
`
`
`
`
`teach ‘direct communication’ between a client and target computer.” VirnetX, Inc.,
`
`Case No. IPR2015-01046
`
`767 F.3d at 1323-24 (emphasis added). The Federal Circuit noted that “VPN,” as
`
`recited in the claims of the ’135 patent, was construed “to mean ‘a network of
`
`computers which privately and directly communicate with each other by
`
`encrypting
`
`traffic on
`
`insecure paths between
`
`the computers where
`
`the
`
`communication is both secure and anonymous.” VirnetX, Inc., 767 F.3d at 1317.
`
`The Federal Circuit explained that Kiuchi did not anticipate the asserted claims of
`
`the ’135 patent:
`
`[T]he jury heard expert testimony that Kiuchi’s client-
`side and server-side proxies terminate the connection,
`process information, and create a new connection--
`actions that are not “direct” within the meaning of the
`asserted claims. . . . VirnetX distinguished